Robert Blum

Robert Blum joined Gamida Cell’s Board of Directors as Chairman in September 2018, bringing 40 years of experience in the biopharmaceutical industry. Mr. Blum started Cytokinetics in 1998 and served in roles of increasing responsibility before being appointed President and Chief Executive Officer in 2007. Previously, he held senior positions in business and commercial development at COR Therapeutics and roles of increasingly responsibility in sales, marketing and planning functions at Marion Laboratories and Syntex Corporation. Additionally, Mr. Blum served on the National Board of the American Committee of the Weizmann Institute of Science and established the Blum Family Venture Philanthropy Fund to advance translational science discoveries with potential to benefit the Israeli life sciences economy. He serves on the Board of San Francisco’s Jewish Family & Children’s Services and Temple Emanu-el and previously served on the Board of other Bay Area Jewish community non-profits. He founded and chaired the Business Leadership Council of the Jewish Community Federation and is a Founding Board Member of Life Science Cares-Bay Area. Mr. Blum is a Henry Crown Fellow of the Aspen Institute, awarded in recognition of his leadership in corporate and civic responsibilities.

Mr. Blum holds bachelor’s degrees in human biology and economics from Stanford University and an MBA from Harvard Business School.